(0.24) million due to most customers in the government sector changing their bidding process to E-bidding which has lower cost and expense. (Unit : Million Baht) 2018 2017 Change % Change Revenue from
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
remuneration, employees’ salaries of the office and branches, medical supplies and other supplies, laboratory expense and tourism cost by Baht 4.46 million, Baht 2.59 million, Baht 1.72 million, Baht 2.27
and total portfolio and a strong growth of both domestic and overseas subsidiaries. In addition, the Company efficiently managed the selling, general and administrative expense and funding cost. 2
cost management, and well administrative expense controlling. Moreover, during three months of Q3 2017, the Group’s net loss was 1.23 Million Baht which effected from PTT MCS’s cost adjustment that
raw materials in the world market. At the same time, the average cost of raw material was adjusted lower slower than the lower selling price in market. 4 (Unit: Baht million) Consolidated balance sheets
ready for sale, therefore the interest expense of which cannot be capitalized as the project cost. For the full year 2018, the Company has the financial cost of THB 149.0mn, compared to THB 77.1mn for the
169.47 49.05% Cost of rendering of services (228.29) (355.37) (127.08) 55.67% Gross profit 117.24 159.63 42.39 36.16% Other income 0.10 0.69 0.59 570.56% Services expenses (4.59) (6.83) (2.24) 48.74